Home| Professor of Diabetes and Clinical Research |
Publications since 2001
• Pozzilli P, Guglielmi C. Double diabetes: a mixture of type 1 and type 2 diabetes in youth. Endocr Dev. 2009;14:151-66.
• Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, Julier C, Morahan G, Nerup J, Nierras C, Plagnol V, Pociot F, Schuilenburg H, Smyth DJ, Stevens H, Todd JA, Walker NM, Rich SS; The Type 1 Diabetes Genetics Consortium. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009, e-pub 2009 May 10.
• Pozzilli P, Leslie RD. New prospects for immunotherapy at diagnosis of type 1 diabetes. Diabetes Metab Res Rev. 2009 May;25(4):299-301.
• Pozzilli P, Guglielmi C. Double diabetes: a mixture of type 1 and type 2 diabetes in youth. Endocr Dev. 2009;14:151-66.
• Khoo CP, Valorani MG, Brittan M, Alison MR, Warnes G, Johansson U, Hawa M, Pozzilli P. Characterization of endothelial progenitor cells in the NOD mouse as a source for cell therapies. Diabetes Metab Res Rev. 2009 Jan;25(1):89-93.
• Cernea S, Pozzilli P. New potential treatments for protection of pancreatic B-cell function in Type 1 diabetes. Diabet Med. 2008 Nov;25(11):1259-67.
• Beyan H, Buckley LR, Bustin SA, Yousaf N, Pozzilli P, Leslie RD. Altered monocyte cyclo-oxygenase response in non-obese diabetic mice. Clin Exp Immunol. 2009 Feb;155(2):304-10.
• Pronina EA, Petraikina EE, Antsiferov MB, Duchareva OV, Petrone A, Buzzetti R, Pozzilli P. A 10-year (1996-2005) prospective study of the incidence of Type 1 diabetes in Moscow in the age group 0-14 years. Diabet Med. 2008 Aug;25(8):956-9.
• Khoo CP, Pozzilli P, Alison MR. Endothelial progenitor cells and their potential therapeutic applications. Regen Med. 2008 Nov;3(6):863-76.
• Hawa MI, Thivolet C, Mauricio D, Alemanno I, Cipponeri E, Collier D, Hunter S, Buzzetti R, de Leiva A, Pozzilli P, Leslie RD; Action LADA Group. Metabolic syndrome and autoimmune diabetes: action LADA 3. Diabetes Care. 2009 Jan;32(1):160-4.
• Greenbaum CJ, Mandrup-Poulsen T, McGee PF, Battelino T, Haastert B, Ludvigsson J, Pozzilli P, Lachin JM, Kolb H; Type 1 Diabetes Trial Net Research Group; European C-Peptide Trial Study Group. Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care. 2008 Oct;31(10):1966-71.
• Leslie RD, Kolb H, Schloot NC, Buzzetti R, Mauricio D, De Leiva A, Yderstraede K, Sarti C, Thivolet C, Hadden D, Hunter S, Schernthaner G, Scherbaum W, Williams R, Pozzilli P. Diabetes classification: grey zones, sound and smoke: Action LADA 1. Diabetes Metab Res Rev. 2008 Oct;24(7):511-9.
• Noble JA, Martin A, Valdes AM, Lane JA, Galgani A, Petrone A, Lorini R, Pozzilli P, Buzzetti R, Erlich HA. Type 1 diabetes risk for human leukocyte antigen (HLA)-DR3 haplotypes depends on genotypic context: association of DPB1 and HLA class I loci among DR3- and DR4-matched Italian patients and controls. Hum Immunol. 2008 Apr-May;69(4-5):291-300.
• Cavallo MG, Pozzilli P, Misiti S, Baroni MG. Insulinoma CM cell line as in vitro model for beta-cell. J Cell Physiol. 2008 Aug;216(2):568.
• 14: Cardwell CR, Stene LC, Joner G, Cinek O, Svensson J, Goldacre MJ, Parslow RC, Pozzilli P, Brigis G, Stoyanov D, Urbonaite B, Sipetić S, Schober E, Ionescu-Tirgoviste C, Devoti G, de Beaufort CE, Buschard K, Patterson CC. Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia. 2008 May;51(5):726-35.
• Gentilucci UV, Picardi A, Manfrini S, Khazrai YM, Fioriti E, Altomare M, Guglielmi C, Di Stasio E, Pozzilli P. Westernization of the Filipino population resident in Rome: obesity, diabetes and hypertension. Diabetes Metab Res Rev. 2008 Jul-Aug;24(5):364-70.
• Petrone A, Spoletini M, Zampetti S, Capizzi M, Zavarella S, Osborn J, Pozzilli P, Buzzetti R; Immunotherapy Diabetes (IMDIAB) Group. The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control. Diabetes Care. 2008 Jun;31(6):1214-8.
• Pitocco D, DiStasio E, Crinò A, Manfrini S, Guglielmi C, Visalli N, Suraci C, Matteoli MC, Cavallo MG, Bizzarri C, Pozzilli P; IMDIAB Group. Age at diagnosis of type 1 diabetes and the effect of immunomodulatory therapies on residual beta cell function. Horm Metab Res. 2008 Jan;40(1):66-8.
• Brophy S, Yderstraede K, Mauricio D, Hunter S, Hawa M, Pozzilli P, Schernthaner G, Schloot N, Buzzetti R, Davies H, Leslie D, Williams R; Action LADA Group. Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. Diabetes Care. 2008 Mar;31(3):439-41.
• Petrone A, Suraci C, Capizzi M, Giaccari A, Bosi E, Tiberti C, Cossu E, Pozzilli P, Falorni A, Buzzetti R; NIRAD Study Group. The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes NIRAD) Study 3. Diabetes Care. 2008 Mar;31(3):534-8.
• Pozzilli P, Guglielmi C, Pronina E, Petraikina E. Double or hybrid diabetes associated with an increase in type 1 and type 2 diabetes in children and youths. Pediatr Diabetes. 2007 Dec;8 Suppl 9:88-95.
• Spoletini M, Petrone A, Zampetti S, Capizzi M, Zavarella S, Osborn J, Foffi C, Tuccinardi D, Pozzilli P, Buzzetti R; IMDIAB Group. Low-risk HLA genotype in Type 1 diabetes is associated with less destruction of pancreatic B-cells 12 months after diagnosis. Diabet Med. 2007 Dec;24(12):1487-90.
• Chianelli M, Parisella MG, Visalli N, Mather SJ, D'Alessandria C, Pozzilli P, Signore A; IMDIAB study group. Pancreatic scintigraphy with 99mTc-interleukin-2 at diagnosis of type 1 diabetes and after 1 year of nicotinamide therapy. Diabetes Metab Res Rev. 2008 Feb;24(2):115-22.
• Locatelli M, Buzzetti R, Galgani A, Montemari AL, Khazrai M, Petrone A, Visalli N, Meschi F, Minicucci L, Lorini R, Cristaldi A, Valorani MG, Bottazzo GF, Pozzilli P; DIABFIN Study Group. Length of gestation and gender are associated with HLA genotypes at risk for Type 1 diabetes (Italian DIABFIN 3). Diabet Med. 2007 Aug;24(8):916-9.
• Home PD, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ; RECORD Study Group. Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis. N Engl J Med. 2007 Jul 5;357(1):28-38. Epub 2007 Jun 5.
• Pozzilli P. Immuno-intervention and preservation of beta-cell function in type 1 diabetes. Diabetes Metab Res Rev. 2007 May;23(4):255-6.
• Pozzilli P, Buzzetti R. A new expression of diabetes: double diabetes. Trends Endocrinol Metab. 2007 Mar;18(2):52-7.
• Pozzilli P, Guglielmi C. Immunomodulation for the prevention of SPIDDM and LADA. Ann N Y Acad Sci. 2006 Oct;1079:90-8.
• Picardi A, Visalli N, Lauria A, Suraci C, Buzzetti R, Merola MK, Manfrini S, Guglielmi C, Gentilucci UV, Pitocco D, Crinò A, Bizzarri C, Cappa M, Pozzilli P. Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes. Horm Metab Res. 2006 Oct;38(10):668-72.
• Gentilucci UV, Picardi A, Pozzilli P. Glucose abnormalities in patients with hepatitis C virus infection: epidemiology and pathogenesis: response to Lecube et al.Diabetes Care. 2006 Nov;29(11):2558-9.
• Ou D, Wang X, Metzger DL, Ao Z, Pozzilli P, James RF, Chen L, Warnock GL.Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway. Cell Transplant. 2006;15(5):399-410.
• Pitocco D, Crinò A, Di Stasio E, Manfrini S, Guglielmi C, Spera S, Anguissola GB, Visalli N, Suraci C, Matteoli MC, Patera IP, Cavallo MG, Bizzarri C, Pozzilli P; IMDIAB Group. The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI). Diabet Med. 2006 Aug;23(8):920-3.
• Prisco F, Picardi A, Iafusco D, Lorini R, Minicucci L, Martinucci ME, Toni S, Cerutti F, Rabbone I, Buzzetti R, Crino A, Pozzilli P. Blood ketone bodies in patients with recent-onset type 1 diabetes (a multicenter study). Pediatr Diabetes. 2006 Aug;7(4):223-8.
• Picardi A, Valorani MG, Vespasiani Gentilucci U, Manfrini S, Ciofini O, Cappa M, Guglielmi C, Pozzilli P; IMDIAB Group. Raised C-reactive protein levels in patients with recent onset type 1 diabetes. Diabetes Metab Res Rev. 2007 Mar;23(3):211-4.
• Genovese S, Bazzigaluppi E, Gonçalves D, Ciucci A, Cavallo MG, Purrello F, Anello M, Rotella CM, Bardini G, Vaccaro O, Riccardi G, Travaglini P, Morenghi E, Bosi E, Pozzilli P. Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes. Eur J Endocrinol. 2006 Mar;154(3):441-7.
• Leslie RD, Williams R, Pozzilli P. Clinical review: Type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow. J Clin Endocrinol Metab. 2006 May;91(5):1654-9.
• Hawa MI, Picardi A, Costanza F, D'Avola D, Beretta Anguissola G, Guglielmi C, Mottini G, Fezeu L, Mbanya JC, Leslie RD, Pozzilli P. Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon. Clin Immunol. 2006 Feb-Mar;118(2-3):229-32.
• Lorini R, Minicucci L, Napoli F, Padovani P, Bazzigaluppi E, Tortoioli C, Cherubini V, Bottazzo G, Pozzilli P, Falorni A, Buzzetti R. Screening for type 1 diabetes genetic risk in newborns of continental Italy. primary prevention (Prevefin Italy )--preliminary data. Acta Biomed Ateneo Parmense. 2005;76 Suppl 3:31-5.
• Pitocco D, Crino A, Di Stasio E, Manfrini S, Guglielmi C, Spera S, Anguissola GB, Visalli N, Suraci C, Matteoli MC, Patera IP, Cavallo MG, Bizzarri C, Pozzilli P; IMDIAB Group. The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI). Diabet Med. 2006 Aug;23(8):920-3.
• Prisco F, Picardi A, Iafusco D, Lorini R, Minicucci L, Martinucci ME, Toni S, Cerutti F, Rabbone I, Buzzetti R, Crino A, Pozzilli P. Blood ketone bodies in patients with recent-onset type 1 diabetes (a multicenter study). Pediatr Diabetes. 2006 Aug;7(4):223-8.
• Picardi A, Valorani MG, Vespasiani Gentilucci U, Manfrini S, Ciofini O, Cappa M, Guglielmi C, Pozzilli P. Raised C-reactive protein levels in patients with recent onset type 1 diabetes. Diabetes Metab Res Rev. 2006 Jul 11;
• Genovese S, Bazzigaluppi E, Goncalves D, Ciucci A, Cavallo MG, Purrello F, Anello M, Rotella CM, Bardini G, Vaccaro O, Riccardi G, Travaglini P, Marenghi E, Bosi E, Pozzilli P. Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes. Eur J Endocrinol. 2006 Mar;154(3):441-7.
• Leslie RD , Williams R, Pozzilli P. Clinical review: Type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow. J Clin Endocrinol Metab. 2006 May;91(5):1654-9. Epub 2006 Feb 14
• Pozzilli P, Manfrini S, Crino A, Picardi A, Leomanni C, Cherubini V, Valente L, Khazrai M, Visalli N; IMDIAB group. Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Horm Metab Res. 2005 Nov;37(11):680-3.
• Hawa MI, Picardi A, Costanza F, D'Avola D, Beretta Anguissola G, Guglielmi C, Mottini G, Fezeu L, Mbanya JC, Leslie RD, Pozzilli P. Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon. Clin Immunol. 2006 Feb-Mar;118(2-3):229-32.
• Crino A, Schiaffini R, Ciampalini P, Suraci MC, Manfrini S, Visalli N, Matteoli MC, Patera P, Buzzetti R, Guglielmi C, Spera S, Costanza F, Fioriti E, Pitocco D, Pozzilli P; IMDIAB Group. A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2005 Aug;18(8):749-54.
• Ou D, Wang X, Metzger DL, Robbins M, Huang J, Jobin C, Chantler JK, James RF, Pozzilli P, Tingle AJ. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB. Hum Immunol. 2005 Jul;66(7):799-809.
• Pozzilli P, Manfrini S, Costanza F, Coppolino G, Cavallo MG, Fioriti E, Modi P. Biokinetics of buccal spray insulin in patients with type 1 diabetes. Metabolism. 2005 Jul;54(7):930-4.
• Pozzilli P, Manfrini S, Buzzetti R, Lampeter E, Leeuw ID, Iafusco D, Prisco M, Ionescu-Tirgoviste C, Kolouskova S, Linn T, Ludvigsson J, Madacsy L, Mrozikiewicz AS, Mrozikiewicz PM, Podar T, Vavrinec J, Vialettes B, Visalli N, Yilmaz T, Browne PD; IMDIAB group. Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study. Diabetes Res Clin Pract. 2005 Jun;68(3):258-64.
• Petrone A, Galgani A, Spoletini M, Alemanno I, Di Cola S, Bassotti G, Picardi A, Manfrini S, Osborn J, Pozzilli P, Buzzetti R. Residual insulin secretion at diagnosis of type 1 diabetes is independently associated with both, age of onset and HLA genotype. Diabetes Metab Res Rev. 2005 May-Jun;21(3):271-5.
• Ou D, Wang X, Metzger DL, James RF, Pozzilli P, Plesner A, Korneluk RG, Verchere CB, Tingle AJ. Synergistic inhibition of tumor necrosis factor-related apoptosis-inducing igand-induced apoptosis in human pancreatic beta cells by Bcl-2 and X-linked inhibitor of apoptosis. Hum Immunol. 2005 Mar;66(3):274-84.
• Carle F, Gesuita R, Bruno G, Coppa GV, Falorni A, Lorini R, Martinucci ME, Pozzilli P, Prisco F, Songini M, Tenconi MT, Cherubini V; RIDI Study Group. Diabetes incidence in 0- to 14-year age-group in Italy : a 10-year prospective study. Diabetes Care. 2004 Dec;27(12):2790-6.
• Valeri C, Pozzilli P, Leslie D. Glucose control in diabetes. Diabetes Metab Res Rev. 2004 Nov-Dec;20 Suppl 2:S1-8.
• Monetini L, Cavallo MG, Sarugeri E, Sentinelli F, Stefanini L, Bosi E, Thorpe R, Pozzilli P; Immunotherapy Diabetes (IMDIAB) group. Cytokine profile and insulin antibody IgG subclasses in patients with recent onset type 1 diabetes treated with oral insulin. Diabetologia. 2004 Oct;47(10):1795-802.
• Hawa MI, Valorani MG, Buckley LR, Beales PE, Afeltra A, Cacciapaglia F, Leslie RD, Pozzilli P. Lack of effect of vitamin D administration during pregnancy and early life on diabetes incidence in the non-obese diabetic mouse. Horm Metab Res. 2004 Sep;36(9):620-4.
• Valorani MG, Hawa MI, Buckley LR, Afeltra A, Cacciapaglia F, Pozzilli P. The natural history of insulin content in the pancreas of female and male non-obese diabetic mouse: implications for trials of diabetes prevention in humans. Diabetes Metab Res Rev. 2004 Sep-Oct;20(5):394-8.
• Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, Zheng W, Purohit S, Podolsky RH, Muir A, Wang J, Dong Z, Brusko T, Atkinson M, Pozzilli P, Zeidler A, Raffel LJ, Jacob CO, Park Y, Serrano-Rios M, Larrad MT, Zhang Z, Garchon HJ, Bach JF, Rotter JI, She JX, Wang CY. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet. 2004 Aug;36(8):837-41. Epub 2004 Jul 11. Erratum in: Nat Genet. 2004 Sep;36(9):1024.
• Crino A, Schiaffini R, Manfrini S, Mesturino C, Visalli N, Beretta Anguissola G, Suraci C, Pitocco D, Spera S, Corbi S, Matteoli MC, Patera IP, Manca Bitti ML, Bizzarri C, Pozzilli P; IMDIAB group. A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX). Eur J Endocrinol. 2004 May;150(5):719-24.
• Buzzetti R, Galgani A, Petrone A, Del Buono ML, Erlich HA, Bugawan TL, Lorini R, Meschi F, Multari G, Pozzilli P, Locatelli M, Bottazzo G, Di Mario U. Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease (the DIABFIN study). Diabetes Metab Res Rev. 2004 Mar-Apr;20(2):137-43.
• Mottini G, D'Avola D, Dimbelolo JC, Lumu R, Gallizioli E, Nisita J, Manfrini S, De Clerck M, Pozzilli P. A hospital survey of the clinical features of diabetes in Congo . Diabetes Nutr Metab. 2003 Aug;16(4):236-42.
• Pozzilli P, Crino A, Schiaffini R, Manfrini S, Fioriti E, Coppolino G, Pitocco D, Visalli N, Corbi S, Spera S, Suraci C, Cervoni M, Matteoli MC, Patera IP, Ghirlanda G; The IMDIAB Group. A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8). Diabetes Technol Ther. 2003;5(6):965-74.
• Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS, Pozzilli P, Skyler JS, Steffes MW. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function. Diabetes. 2004 Jan;53(1):250-64.
• Signore A, Annovazzi A, Giacalone P, Beales PE, Valorani MG, Vestri AR, Ruberti G, Manfrini S, Pozzilli P, Bulfone-Paus S. Reduced cumulative incidence of diabetes but not insulitis following dministration of chimeric human IL-15-murine IgG2b in NOD mice. Diabetes Metab Res Rev. 2003 Nov-Dec;19(6):464-8.
• Pozzilli P, Manfrini S, Picardi A. Cow's milk and trials for prevention of Type 1 diabetes. Diabet Med. 2003 Nov;20(11):871-2.
• Picardi A, Pozzilli P. Dynamic tests in the clinical management of diabetes. J Endocrinol Invest. 2003;26(7 Suppl):99-106.
• Visalli N, Sebastiani L, Adorisio E, Conte A, De Cicco AL, D'Elia R, Manfrini S, Pozzilli P; IMDIAB Group. Environmental risk factors for type 1 diabetes in Rome and province. Arch Dis Child. 2003 Aug;88(8):695-8.
• Pozzilli P, Adorini L. Prevention of type 1 diabetes: where do we start? J Endocrinol Invest. 2003 Apr;26(4):292-3.
• Picardi A, Gentilucci UV, Zardi EM, Caccavo D, Petitti T, Manfrini S, Pozzilli P, Afeltra A. TNF-alpha and growth hormone resistance in patients with chronic liver disease. J Interferon Cytokine Res. 2003 May;23(5):229-35.
• Battelino T, Ursic-Bratina N, Dolzan V, Stopar-Obreza M, Pozzilli P, Krzisnik C, Vidan-Jeras B. The HLA-DRB, -DQB polymorphism and anti-insulin antibody response in Slovenian patients with type 1 diabetes. Eur J Immunogenet. 2003 Jun;30(3):223-7.
• Bugawan TL, Mirel DB, Valdes AM, Panelo A, Pozzilli P, Erlich HA. Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos. Am J Hum Genet. 2003 Jun;72(6):1505-14.
• Flohe SB, Wasmuth HE, Kerad JB, Beales PE, Pozzilli P, Elliott RB, Hill JP, Scott FW, Kolb H. A wheat-based, diabetes-promoting diet induces a Th1-type cytokine bias in the gut of NOD mice. Cytokine. 2003 Feb 7;21(3):149-54.
• Beyan H, Valorani MG, Pozzilli P. - to: Gale EAM (2002) A missing link in the hygiene hypothesis? Diabetologia 45:588-592. Diabetologia. 2003 Feb;46(2):301-2.
• Signore A, Picarelli A, Annovazzi A, Britton KE, Grossman AB, Bonanno E, Maras B, Barra D, Pozzilli P. 123I-Interleukin-2: biochemical characterization and in vivo use for imaging autoimmune diseases. Nucl Med Commun. 2003 Mar;24(3):305-16.
• Buzzetti R, Pozzilli P, Di Mario U, Ballerini C, Massacesi L. Multiple sclerosis and Type I diabetes. Diabetologia. 2002 Dec;45(12):1735-6.
• Monetini L, Barone F, Stefanini L, Petrone A, Walk T, Jung G, Thorpe R, Pozzilli P, Cavallo MG. Establishment of T cell lines to bovine beta-casein and beta-casein-derived epitopes in patients with type 1 diabetes. J Endocrinol. 2003 Jan;176(1):143-50.
• Beales PE, Castri F, Valiant A, Rosignoli G, Buckley L, Pozzilli P. Adrenalitis in the non-obese diabetic mouse. Autoimmunity. 2002 Aug;35(5):329-33.
• Ou D, Metzger DL, Wang X, Huang J, Pozzilli P, Tingle AJ. TNF-related apoptosis-inducing ligand death pathway-mediated human beta-cell destruction. Diabetologia. 2002 Dec;45(12):1678-88
• Bugawan TL, Klitz W, Alejandrino M, Ching J, Panelo A, Solfelix CM, Petrone A, Buzzetti R, Pozzilli P, Erlich HA. The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos. Tissue Antigens. 2002 Jun;59(6):452-69.
• Petrone A, Battelino T, Krzisnik C, Bugawan T, Erlich H, Di Mario U, Pozzilli P, Buzzetti R. Similar incidence of type 1 diabetes in two ethnically different populations ( Italy and Slovenia ) is sustained by similar HLA susceptible/protective haplotype frequencies. Tissue Antigens. 2002 Sep;60(3):244-53.
• Dorff G, Meyer G, Krone D, Pozzilli P, Zuhlke H. Neuronal NO synthase and its inhibitor PIN are present and influenced by glucose in the human beta-cell line CM and in rat INS-1 cells. Biol Chem. 2002 Sep;383(9):1357-61.
• Beales PE, Elliott RB, Flohe S, Hill JP, Kolb H, Pozzilli P, Wang GS, Wasmuth H, Scott FW. A multi-centre, blinded international trial of the effect of A(1) and A(2) beta-casein variants on diabetes incidence in two rodent models of spontaneous Type I diabetes. Diabetologia. 2002 Sep;45(9):1240-6.
• Pozzilli P. The DPT-1 trial: a negative result with lessons for future type 1 diabetes prevention. Diabetes Metab Res Rev. 2002 Jul-Aug;18(4):257-9.
• Monetini L, Cavallo MG, Manfrini S, Stefanini L, Picarelli A, Di Tola M, Petrone A, Bianchi M, La Presa M, Di Giulio C, Baroni MG, Thorpe R, Walker BK, Pozzilli P; IMDIAB Group. Antibodies to bovine beta-casein in diabetes and other autoimmune diseases. Horm Metab Res. 2002 Aug;34(8):455-9.
• Klitz W, Bugawan TL, Panelo A, Solfelix CM, Buzzetti R, Pozzilli P, Steiner L, Alejandrino M, Erlich HA. Association of CTLA-4 variation with type I diabetes in Filipinos. Immunogenetics. 2002 Aug;54(5):310-3.
• Ou D, Metzger DL, Wang X, Pozzilli P, Tingle AJ. beta-cell antigen-specific CD56(+) NKT cells from type 1 diabetic patients: autoaggressive effector T cells damage human CD56(+) beta cells by HLA-restricted and non-HLA-restricted pathways. Hum Immunol. 2002 Apr;63(4):256-70.
• Beales PE , Pozzilli P. Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes. Diabetes Metab Res Rev. 2002 Mar-Apr;18(2):114-7.
• Nistico L, Giorgi G, Giordano M, Galgani A, Petrone A, D'Alfonso S, Federici M, Di Mario U, Pozzilli P, Buzzetti R, Cascino I. IL12B polymorphism and type 1 diabetes in the Italian population: a case-control study. Diabetes. 2002 May;51(5):1649-50.
• Leslie RD , Pozzilli P. An introduction to new advances in diabetes. Diabetes Metab Res Rev. 2002 Jan-Feb;18 Suppl 1:S1-6.
• Bottini N, Meloni GF, Borgiani P, Giorgini A, Buzzetti R, Pozzilli P, Lucarelli P, Gloria-Bottini F. Genotypes of cytosolic low-molecular-weight protein-tyrosine-phosphatase correlate with age at onset of type 1 diabetes in a sex-specific manner. Metabolism. 2002 Apr;51(4):419-22.
• Pozzilli P, Mesturino CA, Crino A, Gross TM, Jeng LM, Visalli N; IMDIAB Group. Is the process of beta-cell destruction in type 1 diabetes at time of diagnosis more extensive in females than in males? Eur J Endocrinol. 2001 Dec;145(6):757-61.
• Pozzilli P, Manfrini S, Monetini L. Biochemical markers of type 1 diabetes: clinical use. Scand J Clin Lab Invest Suppl. 2001;235:38-44.
• Pozzilli P, Di Mario U. Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention. Diabetes Care. 2001 Aug;24(8):1460-7.
• Cavallo MG, Coppolino G, Romeo S, Pozzilli P. Inhaled insulin in type 1 diabetes. Lancet. 2001 Jun 16;357(9272):1980.
• Crino A, Cavallo MG, Corbi S, Mesturino CA, Ferrazzoli F, Coppolino G, Bizzarri C, Cervoni M, Monetini L, Pozzilli P; IMDIAB Group. Intradermal skin test with diabetes specific antigens in patients with type 1 diabetes. Clin Exp Immunol. 2001 Mar;123(3):382-6.
• Cavallo MG, Romeo S, Coppolino G, Pozzilli P. Continuous glucose monitoring during the European Soccer cup semifinal, Italy against Holland . Diabetologia. 2001 Feb;44(2):268.
• Multari G, Werner B, Cervoni M, Lubrano R, Costantino F, Demiraj V, Pozzilli P. Peritoneal dialysis in an infant with type 1 diabetes and hyperosmolar coma. J Endocrinol Invest. 2001 Feb;24(2):104
• Monetini L, Cavallo MG, Stefanini L, Ferrazzoli F, Bizzarri C, Marietti G, Curro V, Cervoni M, Pozzilli P; IMDIAB Group. Bovine beta-casein antibodies in breast- and bottle-fed infants: their relevance in Type 1 diabetes. Diabetes Metab Res Rev. 2001 Jan-Feb;17(1):51-4.